Creating a bank of tumor tissue samples for research
Establishment of a Tissue Sample Bank in the Field of Gynaecological Oncology
This study is creating a collection of tumor tissue samples from cancer patients and healthy individuals to help researchers find better ways to diagnose and treat cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medical University of Vienna Academic / other |
| Locations | 3 sites (Vienna and 2 other locations) |
| Trial ID | NCT01789229 on ClinicalTrials.gov |
What this trial studies
This project aims to establish a comprehensive tumor bank that collects tissue samples from patients with various types of tumors, including benign and malignant cases, as well as healthy controls. The samples will be systematically gathered alongside corresponding clinical data to support future research in cancer diagnosis and therapy. The tumor bank will facilitate translational oncology by providing essential biological materials for analyzing tumor markers and genetic characteristics, ultimately aiming to improve clinical outcomes for cancer patients.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18 to 90 with a single known malignant or inflammatory disease.
Not a fit: Patients with multiple malignancies or inflammatory diseases, as well as those under 18, may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could significantly enhance cancer research and lead to improved diagnostic and therapeutic strategies for patients.
How similar studies have performed: Other studies have successfully established tumor banks, indicating that this approach is both viable and beneficial for advancing cancer research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male/Female * Age 18 to 90 years max. * Just one current known malignant disease or just one current inflammatory disease Exclusion Criteria: * Inflammatory disease and malignant disease * multiple malignancies * multiple diseases * underage
Where this trial is running
Vienna and 2 other locations
- Medical University Vienna, Dptm. of Obstetrics & Gynaecology — Vienna, Austria (Recruiting)
- University Hospitals Leuven - Department of Obstetrics and Gynaecology — Leuven, Belgium (Completed)
- Charité University - Campus Virchow Chlinic — Berlin, Germany (Active_not_recruiting)
Study contacts
- Principal investigator: Robert Zeillinger, Prof.Dr. — Medical University of Vienna, Dptm. of Obstetrics & Gynaecology
- Study coordinator: Robert Zeillinger, Prof.Dr.
- Email: robert.zeillinger@meduniwien.ac.at
- Phone: +43140400
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.